ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,571Medicare Part D Prescriptions Filled, Including Refills

Rank: 243 out of 4623

$684K Total Retail Price of All Prescriptions

Rank: 381 out of 4623

572 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 572 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 11,916 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LISINOPRIL 865 770 1 4
PRAVASTATIN SODIUM 789 718 2 11
SERTRALINE HCL 675 624 3 26
METFORMIN HCL 524 464 4 6
ATORVASTATIN CALCIUM 490 418 5 12
LEVOTHYROXINE SODIUM 418 360 6 1
HYDROCHLOROTHIAZIDE 391 359 7 10
BISOPROLOL FUMARATE 374 327 8 231
TAMSULOSIN HCL 372 328 9 29
FENOFIBRATE 362 317 10 54
LISINOPRIL-HYDROCHLOROTHIAZIDE 353 345 11 19
OMEPRAZOLE 349 309 12 7
GLIMEPIRIDE 347 308 13 38
AMLODIPINE BESYLATE 336 292 14 5
CRESTOR 266 230 15 20
FLUTICASONE PROPIONATE 252 209 16 32
WARFARIN SODIUM 248 213 17 24
FINASTERIDE 239 235 18 109
COMBIVENT 211 195 19 162
RANITIDINE HCL 208 197 20 47
ALENDRONATE SODIUM 205 200 21 22
FUROSEMIDE 187 164 22 8
CITALOPRAM HBR 160 139 23 23
CARVEDILOL 146 112 24 25
PANTOPRAZOLE SODIUM 129 126 25 35
MIRTAZAPINE 126 114 26 57
PREDNISONE 118 110 27 50
LOSARTAN POTASSIUM 116 105 28 21
MELOXICAM 108 81 29 27
LOVASTATIN 102 102 30 34
NEXIUM 94 80 31 17
METOPROLOL SUCCINATE 94 92 31 13
ATROVENT HFA 92 79 33 385
ALLOPURINOL 89 77 34 37
TRIAMCINOLONE ACETONIDE 80 69 35 124
CIPROFLOXACIN HCL 78 69 36 43
TERAZOSIN HCL 76 70 37 143
GABAPENTIN 74 60 38 16
LANTUS SOLOSTAR 71 57 39 105
HUMALOG MIX 75-25 71 26 39 307
DONEPEZIL HCL 69 68 41 30
TRAZODONE HCL 68 61 42 42
HYDRALAZINE HCL 68 61 42 99
LOSARTAN-HYDROCHLOROTHIAZIDE 64 56 44 46
VITAMIN D2 64 56 44 304
PLAVIX 61 57 46 45
SPIRONOLACTONE 60 53 47 77
LIPITOR 60 46 47 100
GEMFIBROZIL 59 58 49 94
CLOPIDOGREL 57 49 50 31
TRAMADOL HCL 57 43 50 15
LANTUS 56 49 52 44
POLYETHYLENE GLYCOL 3350 54 49 53 91
BUPROPION XL 54 45 53 219
INSULIN SYRINGE 53 33 55 85
FLOVENT HFA 52 49 56 403
LOVAZA 50 46 57 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.